未登录

S

Sean D. MacKnight

société à responsabilité illimitée

H指数:8

被引数:305

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Attack rate reductions following berotralstat initiation among US patients with hereditary angioedema in the real-world

在现实世界中患有遗传性血管性水肿的美国患者中，berotralstat启动后的发作率降低

allergy, asthma & clinical immunology

IF0

2026-01-250

OAAI

Effectiveness and safety of rivaroxaban versus warfarin in patients with pulmonary embolism and right ventricular dysfunction: a retrospective cohort study

利伐沙班与华法林在肺栓塞合并右心室功能不全患者中的有效性与安全性：一项回顾性队列研究

Research and Practice in Thrombosis and Haemostasis

IF3.4

2025-06-010

OAAI

Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting

general psychiatry

IF3.1

2025-01-270

OAAI

Pre-Exposure Prophylaxis for the Prevention of HIV-1: An Assessment of Oral Pre-Exposure Prophylaxis Usage Patterns, First Evidence of HIV-1, and HIV-1 Risk Factors in the United States

暴露前预防预防HIV-1: 对美国口服暴露前预防使用模式，HIV-1的第一证据和HIV-1危险因素的评估

AIDS PATIENT CARE AND STDS

IF3.8

2024-11-010

PRE

Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States

美国真实世界美泊利单抗治疗嗜酸性肉芽肿性多血管炎可减轻疾病负担

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

IF4.7

2024-11-010

OAAI

Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

LUPUS SCIENCE & MEDICINE

IF3.5

2024-04-030

OAAI

Impact of Cariprazine on Weight and Blood Pressure in Bipolar I Depression: A Real-World Study Using Electronic Medical Records

IF4.1

2023-04-140

OA

Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE

IF6.6

2022-11-0120

OAAI

The real-world health resource use and costs of misdiagnosing bipolar I disorder

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2022-11-014

OAAI

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States

therapeutic advances in musculoskeletal disease

IF3

2022-08-299

OAAI

Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study

RESPIRATORY MEDICINE

IF3.1

2022-06-0134

OAAI

Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the USA

TARGETED ONCOLOGY

IF4

2020-12-072

OAAI

UMECLIDINIUM/VILANTEROL (UMEC/VI) COMPARED WITH TIOTROPIUM (TIO) FOR TIME-TO-FIRST INPATIENT ADMISSION AMONG PATIENTS WITH COPD IN A MANAGED CARE POPULATION

IF8.6

2020-10-010

OAAI

IMPACT OF UMECLIDINIUM/VILANTEROL (UMEC/VI) VS TIOTROPIUM (TIO), FLUTICASONE PROPIONATE/SALMETEROL (FP/SAL), AND BUDESONIDE/FORMOTEROL (B/F) ON TIME-TO-FIRST SEVERE EXACERBATION AMONG PATIENTS WITH COPD WITH HIGH COMORBIDITIES AND HIGH COSTS

IF8.6

2020-10-010

OAAI

MEDICATION ADHERENCE AND COPD-RELATED COSTS AMONG PATIENTS WITH COPD TREATED WITH UMECLIDINIUM/VILANTEROL (UMEC/VI) VS TIOTROPIUM (TIO)

IF8.6

2020-10-010

OAAI

REAL-WORLD ADHERENCE TO SINGLE-INHALER VS MULTIPLE-INHALER TRIPLE THERAPY AMONG PATIENTS WITH COPD IN A COMMERCIALLY INSURED US POPULATION

IF8.6

2020-10-0111

OAAI

Ibuprofen rescues mutant cystic fibrosis transmembrane conductance regulator trafficking

JOURNAL OF CYSTIC FIBROSIS

IF6

2015-01-0145

OAAI